Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
BörsenkürzelISRG
Name des UnternehmensIntuitive Surgical Inc
IPO-datumJun 13, 2000
CEORosa (David J)
Anzahl der mitarbeiter15638
WertpapierartOrdinary Share
GeschäftsjahresendeJun 13
Addresse1020 Kifer Road
StadtSUNNYVALE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94086
Telefon14085232100
Websitehttps://www.intuitive.com/en-us/about-us/company
BörsenkürzelISRG
IPO-datumJun 13, 2000
CEORosa (David J)
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten